Clinical Trials · NCT00028769
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- SWOG Cancer Research Network
- Enrollment
- 41
- Start date
- Dec 2001
- Locations
- 91 sites, United States
- Primary endpoint
- Progression-free Survival